2-chlorobenzaldehyde has been researched along with Hypertension in 1 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakale, RP; Frampton, C; Gudasi, KB; Mangannavar, CV; Muchchandi, IS; Naik, GN; Shcherbakov, IN | 1 |
1 other study(ies) available for 2-chlorobenzaldehyde and Hypertension
| Article | Year |
|---|---|
Mixed ligand complex via zinc(II)-mediated in situ oxidative heterocyclization of hydrochloride salt of 2-chlorobenzaldehyde hydralazine hydrazone as potential of antihypertensive agent.
Topics: Animals; Antihypertensive Agents; Benzaldehydes; Cobalt; Coordination Complexes; Copper; Crystallography, X-Ray; Cyclization; Fructose; Hydralazine; Hydrazones; Hypertension; Ligands; Male; Molecular Structure; Nickel; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Thermogravimetry; Zinc | 2014 |